Genital Herpes Epidemiology Forecast 2030 By DelveInsight

 Breaking News
  • No posts were found

Genital Herpes Epidemiology Forecast 2030 By DelveInsight

August 12
12:23 2020
Genital Herpes Epidemiology Forecast 2030 By DelveInsight


(Albany, US) DelveInsight has launched a new report Genital Herpes Epidemiology


DelveInsight’s Genital Herpes Epidemiology Forecast to 2030 report delivers an in-depth understanding of the disease, historical and forecasted Genital Herpes epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

Genital Herpes (GH), is a common sexually transmitted disease caused due to two viruses namely: herpes simplex virus 1 (HSV1) and herpes simplex virus 2 (HSV2) characterized by lifelong infection and periodic reactivation with no cure. Viruses penetrate the body through mucous membranes which line the openings of nose, mouth and genitalia.HSV1, HSV2 are found in body fluids of infected person. The appearance of a blister is known as outbreak. First outbreak will appear as early as two days after the virus has been contracted, or as late as 30 days afterward. A visible outbreak consists of single or clustered vesicles on the genitalia, perineum, buttocks, upper thighs, or perianal areas that ulcerate before resolving. Symptoms of primary infection may include malaise, fever, or localized lymphadenopathy. Subsequent outbreaks, caused by reactivation of latent virus, are usually milder. Although HSV-1 and HSV-2 cannot be distinguished visually, they exhibit differences in behavior that may affect management. Patients with HSV-2 have a higher risk of acquiring human immunodeficiency virus (HIV) infection. Genital Herpes is more prevalent among the females as compared to the males




Request for free sample page: – https://www.delveinsight.com/sample-request/genital-herpes-epidemiology-forecast


Genital Herpes Epidemiology Perspective

The Genital Herpes epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Genital Herpes epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Genital Herpes epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Key facts of the report

  • According to DelveInsight, the total prevalent population of Genital Herpes in 7 major markets was 82,662,204 in 2017 and is expected to grow for the study period [2017–2030].
  • DelveInsight also estimates higher prevalence of Genital Herpes in United States with 41,589,239 cases in 2017.
  • Among the European countries, Germany has the highest prevalent population of Genital Herpes with 7,008,717 cases and United Kingdom has lowest number of cases.


Genital Herpes Report Scope

  • The Genital Herpes report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Genital Herpes Epidemiology Report and Model provide an overview of the risk factors and global trends of Genital Herpes in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Genital Herpes in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Genital Herpes
  • The report provides the segmentation of the Genital Herpes epidemiology


Request for free sample page: – https://www.delveinsight.com/sample-request/genital-herpes-epidemiology-forecast


Table of content

1. Key Insights 

2. Executive Summary of Genital Herpes

3. Genital Herpes: Disease Background and Overview

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. KOL Views

8. Unmet Needs

9.  Appendix

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight


Why should you buy this report?

  • The Genital Herpes Epidemiology report will allow the user to –
  • Develop business strategies by understanding the trends shaping and driving the global Genital Herpes market
  • Quantify patient populations in the global Genital Herpes market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Genital Herpes therapeutics in each of the markets covered
  • Understand the magnitude of Genital Herpes population by its epidemiology
  • The Genital Herpes Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Related Reports



About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.



Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/